For example, the SCN4A gene is associated with an actionability score of 9 in the hyperkalemic periodic paralysis (severity score at 1), compared to a score of 11 in the congenital myasthenic syndrome type 16 (severity score at 3) [8]. This evidence concerns the gene SCN4A and congenital myasthenic syndrome 16.